Philip Jull
Voorzitter bij ARROW EXPLORATION CORP.
Vermogen: 2 M $ op 30-04-2024
Profiel
Mr. Philip G.
Jull, CFA MBA, is an Independent Director at GeneTether Therapeutics, Inc., a Chairman at Tryp Therapeutics, Inc. and an Executive Chairman at Arrow Exploration Corp.
He is on the Board of Directors at Tryptamine Therapeutics Ltd., GeneTether Therapeutics, Inc. and GeneTether, Inc. Mr. Jull was previously employed as an Independent Director by Aldridge Minerals, Inc., a Chairman by Bordeaux Capital, Inc., and a Managing Director-Corporate Finance by Mackie Research Capital Corp.
He received his undergraduate degree from the University of Toronto and an MBA from the University of Western Ontario.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ARROW EXPLORATION CORP.
2.10% | 29-04-2024 | 5 993 508 ( 2.10% ) | 2 M $ | 30-04-2024 |
TRYP THERAPEUTICS, INC.
0.48% | 09-01-2024 | 463 829 ( 0.48% ) | 21 800 $ | 30-04-2024 |
| 07-03-2023 | 148 919 ( 0.39% ) | 6 701 $ | 30-04-2024 |
Actieve functies van Philip Jull
| Bedrijven | Functie | Begin |
|---|---|---|
| ARROW EXPLORATION CORP. | Voorzitter | 21-03-2020 |
| TRYPTAMINE THERAPEUTICS LIMITED | Voorzitter | - |
| GENETETHER THERAPEUTICS INC. | Directeur/Bestuurslid | 01-10-2021 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Philip Jull
| Bedrijven | Functie | Einde |
|---|---|---|
Bordeaux Capital, Inc.
 Bordeaux Capital, Inc. Investment ManagersFinance Bordeaux Capital, Inc. focuses on generating and executing transformative financial advisory solutions for public and private corporations. The company was founded by Jaret Anderson, Gage Jull and Max Satel and is headquartered in Toronto, Canada. | Oprichter | 01-01-2022 |
Research Capital Corp.
 Research Capital Corp. Investment Banks/BrokersFinance Research Capital Corp. is an independent, fully integrated national investment dealer headquartered in Toronto, Canada. The firm was founded in 2010 as Mackie Research Capital Corp. until 2021. Research Capital offers a complete range of capital markets and wealth management services to private clients, institutions and growth companies with offices across Canada. | Corporate Officer/Principal | 01-11-2015 |
| ALDRIDGE MINERALS INC. | Directeur/Bestuurslid | - |
Opleiding van Philip Jull
| University of Toronto | Undergraduate Degree |
| University of Western Ontario | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ARROW EXPLORATION CORP. | Energy Minerals |
| GENETETHER THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Bordeaux Capital, Inc.
Bordeaux Capital, Inc. Investment ManagersFinance Bordeaux Capital, Inc. focuses on generating and executing transformative financial advisory solutions for public and private corporations. The company was founded by Jaret Anderson, Gage Jull and Max Satel and is headquartered in Toronto, Canada. | Finance |
Aldridge Minerals, Inc.
 Aldridge Minerals, Inc. Precious MetalsNon-Energy Minerals Aldridge Minerals, Inc. is a development stage mining company. It engages in the business of identifying, acquiring, exploring, and developing mineral properties. The company was founded on June 6, 1994 and is headquartered in Toronto, Canada. | Non-Energy Minerals |
Research Capital Corp.
Research Capital Corp. Investment Banks/BrokersFinance Research Capital Corp. is an independent, fully integrated national investment dealer headquartered in Toronto, Canada. The firm was founded in 2010 as Mackie Research Capital Corp. until 2021. Research Capital offers a complete range of capital markets and wealth management services to private clients, institutions and growth companies with offices across Canada. | Finance |
Tryp Therapeutics, Inc.
 Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tryp Therapeutics, Inc. is a pharmaceutical company, which engages in identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. The company was founded on September 24, 2019 and is headquartered in Kelowna, Canada. | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
